Management of Severe Tricuspid Regurgitation with Right Ventricular Dysfunction
Medical therapy should be the first-line approach for severe tricuspid regurgitation (TR) with right ventricular (RV) dysfunction, with surgical intervention generally avoided in the presence of severe RV dysfunction due to poor outcomes. 1, 2
Initial Medical Management
Diuretic therapy:
Guideline-directed medical therapy (GDMT):
Treatment of underlying conditions:
Diagnostic Assessment
Echocardiographic evaluation:
Assess TR severity using established criteria:
- Central jet ≥50% of right atrium
- Dense continuous wave Doppler signal with triangular shape
- Vena contracta ≥7 mm
- PISA radius >9 mm
- Hepatic vein systolic flow reversal
- EROA ≥0.4 cm²
- Regurgitant volume ≥45 mL/beat 1
Evaluate RV size and function:
Hemodynamic assessment:
- Right heart catheterization to measure systolic pulmonary artery pressure, pulmonary vascular resistance, and right atrial pressure when clinical and non-invasive data are discordant (Class IIa C) 1
Surgical Intervention Considerations
For patients with severe TR and RV dysfunction, surgical options are limited by the following guidelines:
Primary TR:
Secondary TR:
- TV surgery should be considered in patients with severe secondary TR who are symptomatic or have RV dilatation, in the absence of severe RV dysfunction and severe pulmonary vascular disease/hypertension (Class IIa B) 1
- In refractory right-sided HF, severe TR, and previous left-sided valve surgery, reoperation with isolated TV surgery may be considered in the absence of severe RV systolic dysfunction (Class IIb B-NR) 1
Transcatheter Options
- For inoperable patients:
Risk Assessment and Contraindications
High-risk features to identify:
Contraindications:
Timing of Intervention
- Timely intervention before the development of severe RV dysfunction is crucial
- Delaying surgery in symptomatic severe TR can lead to irreversible RV damage, organ failure, and poor surgical outcomes 2, 4
- Patients with severe isolated TR should be considered for intervention before the onset of anemia, organ dysfunction, or significant RV dilatation 4
Follow-up
- Regular echocardiographic surveillance to monitor:
- RV function
- TR severity
- Development of other cardiac abnormalities 2
- Adjust medical therapy as needed based on symptoms and clinical status
The management of severe TR with RV dysfunction requires careful consideration of the extent of RV dysfunction, as severe RV dysfunction significantly worsens surgical outcomes and may contraindicate surgical intervention.